Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
| ▸ | HNF4A | P41235 | 1/20 | 0.60 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.53 |
| ▸ | LTB4R2 | Q9NPC1 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | FABP3 | P05413 | 1/20 | 0.50 |
| ▸ | FABP4 | P15090 | 1/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | BCR | P11274 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1902600 | 0.98 | HSD17B10 (0.63) | HSD17B10HNF4ABCAT2LTB4R2ALDH1A1 | |
| SCHEMBL30292805 | 0.91 | HNF4A (0.63) | HSD17B10HNF4ABCAT2LTB4R2ALDH1A1 | |
| SCHEMBL18759613 | 0.91 | HNF4A (0.63) | HSD17B10HNF4ABCAT2LTB4R2ALDH1A1 | |
| SCHEMBL1252583 | 0.89 | IDE (0.66) | HSD17B10HNF4ABCAT2LTB4R2ALDH1A1 | |
| SCHEMBL11554621 | 0.89 | HNF4A (0.61) | HNF4ABCAT2LTB4R2ALDH1A1ALOX15 | |
| SCHEMBL32677769 | 0.87 | HNF4A (0.64) | HNF4ABCAT2LTB4R2ALDH1A1ALOX15 | |
| SCHEMBL32677772 | 0.87 | HNF4A (0.64) | HNF4ABCAT2LTB4R2ALDH1A1ALOX15 | |
| SCHEMBL505412 | 0.87 | HNF4A (0.64) | HNF4ABCAT2LTB4R2ALDH1A1ALOX15 | |
| Benzene SCHEMBL1403559 | 0.87 | HNF4A (0.69) | HSD17B10HNF4ABCAT2LTB4R2ALDH1A1 | |
| SCHEMBL133057 | 0.87 | HNF4A (0.69) | HSD17B10HNF4ABCAT2LTB4R2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220280494-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | DELPOR, INC. | 2022-09-08 | — | — | US | claimed |
| EP-4021406-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | Delpor, Inc. (US) | 2022-07-06 | — | — | EP | claimed |
| CN-114641291-A | Compositions of small molecule therapeutic compounds | 戴尔普尔有限公司 | 2022-06-17 | — | — | CN | claimed |
| WO-2021041730-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | DELPOR, INC. (US) | 2021-03-04 | — | — | WO | claimed |
| US-20210000740-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | DELPOR, INC. | 2021-01-07 | — | — | US | claimed |
| EP-3758701-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | Delpor, Inc. (US) | 2021-01-06 | — | — | EP | claimed |
| CN-112004538-A | Compositions of small molecule therapeutic compounds | 德尔宝股份有限公司 | 2020-11-27 | — | — | CN | claimed |
| EP-3515407-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | Delpor, Inc. (US) | 2019-07-31 | — | — | EP | claimed |
| EP-3515408-A1 | STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS | Delpor, Inc. (US) | 2019-07-31 | — | — | EP | claimed |
| US-20190224122-A1 | STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS | NATIONAL INSTITUTES OF HEALTH | 2019-07-25 | — | — | US | claimed |
| US-20190224322-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | DELPOR, INC. | 2019-07-25 | — | — | US | claimed |
| WO-2018057968-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | DELPOR, INC. (US) | 2018-03-29 | — | — | WO | claimed |
| WO-2018057977-A1 | STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS | DELPOR, INC. (US) | 2018-03-29 | — | — | WO | claimed |
| US-20090030218-A1 | Method For Producing Aminoalcohol Derivative Having Biphenyl Group | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2009-01-29 | — | — | US | claimed |
| EP-1932826-A1 | METHOD FOR PRODUCING AMINOALCOHOL DERIVATIVE HAVING BIPHENYL GROUP | Kissei Pharmaceutical Co., Ltd. (JP) | 2008-06-18 | — | — | EP | claimed |
| US-6572843-B1 | Combining permanent dyeing and straightening; applying to reduced hair an oxidizing enzyme (Laccase), a mediator, and a chemical oxidizing agent that produces hydrogen peroxide | NOVOZYMES, A/S (DK) | 2003-06-03 | — | — | US | claimed |
| EP-0856025-B1 | CHOLESTERIC PHASE-FORMING POLYMERS AND THEIR USE | CELANESE VENTURES GMBH (DE) | 2003-01-15 | — | — | EP | claimed |
| US-4962163-A | ADVANCED POLYEPOXIDES AND EPOXY RESINS MODIFIED BY AN UNSATURATED CARBOXYLIC ACID; CURED COATING AND FILMS HAVINGI IMPROVED TENSILE AND FLEXURAL STRENGTH AND MODULUS | THE DOW CHEMICAL COMPANY (US) | 1990-10-09 | — | — | US | claimed |
| JP-1079135-A | — | — | None | — | — | JP | disclosed |
| US-4080471-A | ANTIARRYTHMIA | AKTIEBOLAGET HASSLE (SW) | 1978-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030218-A1 | Method For Producing Aminoalcohol Derivative Having Biphenyl Group | ALDH7A1, DDC, ADH5 | HSD17B10 107/4885HNF4A 143/4885BCAT2 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.